Translations:Insulin glargine/8/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
VisualWikitext
FuzzyBot (talk | contribs)
15,166 edits
Importing a new version from external source
 
(No difference)

Latest revision as of 11:00, 20 March 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Insulin glargine)
<!-- Side effects and mechanism -->
Common side effects include [[low blood sugar]], problems at the site of injection, itchiness, and weight gain. Other serious side effects include [[low blood potassium]]. [[NPH insulin]] rather than insulin glargine is generally preferred in [[pregnancy]]. After injection, [[microcrystal]]s slowly release insulin for about 24 hours. This insulin causes body tissues to absorb [[glucose]] from the blood and decreases glucose production by the liver.

Common side effects include low blood sugar, problems at the site of injection, itchiness, and weight gain. Other serious side effects include low blood potassium. NPH insulin rather than insulin glargine is generally preferred in pregnancy. After injection, microcrystals slowly release insulin for about 24 hours. This insulin causes body tissues to absorb glucose from the blood and decreases glucose production by the liver.

Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Insulin_glargine/8/en&oldid=130428"